XML 79 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Narrative) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Sep. 19, 2012
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2012
Biopharmax [Member]
Jun. 30, 2014
Investor Warrants [Member]
Jun. 30, 2013
Investor Warrants [Member]
Jun. 30, 2012
Investor Warrants [Member]
Sep. 19, 2012
Investor Warrants [Member]
Sep. 19, 2012
Underwriters Option [Member]
Sep. 19, 2012
Underwriter Warrants [Member]
Aug. 31, 2012
Consultant Warrants [Member]
Jun. 30, 2014
Consultant Warrants [Member]
Class of Stock [Line Items]                          
Common stock, shares authorized   200,000,000 200,000,000                    
Common stock, par value per share   $ 0.00001 $ 0.00001                    
Preferred stock, shares authorized   10,000,000                      
Preferred stock,, par value per share   $ 0.00001                      
Issuance of common stock and warrants, issuance costs   $ 195 $ 2,694                    
Warrants exercised via cashless exercise           2,517,907 682,213 406,783       36,000 65,000
Warrants exercised via cashless exercise, shares issued           1,469,584 420,199 168,424       26,299 36,970
Warrants exercised for cash           1,432,584 1,201,160 355,411          
Aggregate cash consideration received     2,009 556   1,968 2,009 556          
Options exercised   15,000                      
Options and warrants exercised   66,500                      
Number of warrants exercised           1,432,584 1,201,160 355,411          
Issuance of common stock under CHA agreement   2,500,000                      
Stock based compensation to contractor, shares         1,500,000                
CHA shares classified as marketable securities   1,011,504                      
Issuance of common stock under CHA Agreement (Note 1d)   10,414                      
Issuance of common stock and warrants, net of issuance costs, shares 8,000,000 2,596,032                      
Issuance of common stock and warrants, net of issuance costs   10,644 34,106                    
Offering price per unit $ 4.00                        
Shares covered by each warrant                 0.35        
Warrant exercise price                 $ 5.00        
Warrants for common stock                   1,200,000 420,000    
Proceeds from issuance of stock $ 34,106 $ 10,644 $ 34,106                     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Options authorized   13,256,713                      
Options available for future grant   1,205,080